| Inclusion criteria |
1 | Patients with sepsis who are admitted to the ICU |
2 | Aged 18 to 80 years old. |
3 | Filling the written informed consent before the intervention |
4 | Being able to tolerate enteral nutrition and having a normal digestive function |
5 | Patients with GCS levels lower than 13 |
 | Exclusion criteria |
1 | Dissatisfaction of the patient or his legal guardian |
2 | Patients who stay in the ICU for < 48 h |
3 | Patients receiving parenteral nutrition or transferring to parenteral nutrition due to contraindications |
4 | Cancer patients undergoing chemotherapy |
5 | Patients suffering from pancreatitis, kidney failure, and congenital or immune disorders |
6 | Patients taking phenobarbital, levetiracetam, and phenytoin |
7 | Dialysis patients, patients with severe septic shock or sepsis, and DIC (diffuse intravascular coagulation) |
8 | Pregnancy and breastfeeding |
9 | Patients with BMI < 18.5 kg/m2 |
10 | Patients who need blood transfusions frequently |
11 | Unwanted side effects associated with taking supplements or placebos |
12 | ICU patients who are expected to die within 2 days of admission. |
13 | Patients who take other herbal supplements |
14 | Patients with a spice or herbal supplement allergy |
15 | Patients with GCS levels greater than 13 |
16 | Patients who passed away during the trial |